The antileukaemic activity of 5-Aza-2 deoxycytidine (Aza-dC) in patients with relapsed and resistant leukaemia.

The antileukaemic activity of 5-Aza-2 deoxycytidine (Aza-dC) in patients with relapsed and resistant leukaemia.

In the present study we demonstrate that Aza-dC in combination with Amsacrine has major antileukaemic properties in patients who have not already received extensive Ara-C therapy. Eight out of 11 patients in their first relapse of acute leukaemia achieved complete remission. Cross resistance between...

Full description

Bibliographic Details
Main Authors:	Richel, D. J., Colly, L. P., Kluin-Nelemans, J. C., Willemze, R.
Format:	Online
Language:	English
Published:	1991
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977302/

Similar Items

Comparison of the antileukaemic activity of 5 aza-2-deoxycytidine and arabinofuranosyl-cytosine in rats with myelocytic leukaemia.
by: Richel, D. J., et al.
Published: (1988)

5-Aza-2′-deoxycytidine stress response and apoptosis in prostate cancer
by: Patra, Aditi, et al.
Published: (2011)

5-Aza-2′-deoxycytidine-induced genome rearrangements are mediated by DNMT1
by: Maslov, Alexander Y., et al.
Published: (2012)

AID downregulation is a novel function of the DNMT inhibitor 5-aza-deoxycytidine
by: Tsai, Chiou-Tsun, et al.
Published: (2013)

Synergistic and antagonistic AML cell type-specific responses to 5-AZA-2’-Deoxycytidine and 1-H-D-Arabinofuranosylcytosine
by: Elmoneim, Abeer Abd, et al.
Published: (2014)

5-Azacytidine and 5-aza-2'-deoxycytidine behave as different antineoplastic agents in B16 melanoma.
by: Cortvrindt, R., et al.
Published: (1987)

A Perspective on the Comparative Antileukemic Activity of 5-Aza-2′-deoxycytidine (Decitabine) and 5-Azacytidine (Vidaza)
by: Momparler, Richard L.
Published: (2012)

The epigenetic modifiers 5-aza-2'-deoxycytidine and trichostatin A influence adipocyte differentiation in human mesenchymal stem cells
by: Zych, J., et al.
Published: (2013)

Identification of a class of human cancer germline genes with transcriptional silencing refractory to the hypomethylating drug 5-aza-2′-deoxycytidine.
by: Almatrafi, Ahmed, et al.
Published: (2014)

FOXO3/FKHRL1 is activated by 5-aza-2-deoxycytidine and induces silenced caspase-8 in neuroblastoma
by: Geiger, Kathrin, et al.
Published: (2012)

GSTP1 DNA Methylation and Expression Status Is Indicative of 5-aza-2′-Deoxycytidine Efficacy in Human Prostate Cancer Cells
by: Chiam, Karen, et al.
Published: (2011)

5-Aza-2′-deoxycytidine causes replication lesions that require Fanconi anemia-dependent homologous recombination for repair
by: Orta, Manuel Luís, et al.
Published: (2013)

Epigenetic Therapy of Non-Small Cell Lung Cancer Using Decitabine (5-Aza-2′-Deoxycytidine)
by: Momparler, Richard L.
Published: (2013)

Effects of 5-Aza-2′-deoxycytidine on the methylation state and function of the WWOX gene in the HO-8910 ovarian cancer cell line
by: YAN, HONGCHAO, et al.
Published: (2013)

Pharmacokinetic and pharmacodynamic analysis of 5-aza-2’-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy
by: Karahoca, Metin, et al.
Published: (2013)

5-Aza-2′-deoxycytidine Leads to Reduced Embryo Implantation and Reduced Expression of DNA Methyltransferases and Essential Endometrial Genes
by: Ding, Yu-Bin, et al.
Published: (2012)

Gene expression profiling of the synergy of 5-aza-2′-deoxycytidine and paclitaxel against renal cell carcinoma
by: Han, Tiandong, et al.
Published: (2012)

Antineoplastic activity of the DNA methyltransferase inhibitor 5-aza-2′-deoxycytidine in anaplastic large cell lymphoma
by: Hassler, Melanie R., et al.
Published: (2012)

Anticancer efficacy of cisplatin and trichostatin A or 5-aza-2′-deoxycytidine on ovarian cancer
by: Meng, F, et al.
Published: (2013)

Treating Cloned Embryos, But Not Donor Cells, with 5-aza-2’-deoxycytidine Enhances the Developmental Competence of Porcine Cloned Embryos
by: HUAN, Yan Jun, et al.
Published: (2013)

Delineating the effect of demethylating agent 5-aza-2′-deoxycytidine on human Caco-2 colonic carcinoma cells
by: LI, XIUMEI, et al.
Published: (2016)

DNA demethylation caused by 5-Aza-2′-deoxycytidine induces mitotic alterations and aneuploidy
by: Costa, Giuseppe, et al.
Published: (2016)

Regulation of TIMP-1 in Human Placenta and Fetal Membranes by lipopolysaccharide and demethylating agent 5-aza-2'-deoxycytidine
by: Vincent, Zoë L., et al.
Published: (2015)

DNA demethylation by 5-aza-2′-deoxycytidine is imprinted, targeted to euchromatin, and has limited transcriptional consequences
by: Ramos, María-Paz, et al.
Published: (2015)

Sequential treatment with 5‐aza‐2′‐deoxycytidine and deacetylase inhibitors reactivates HIV‐1
by: Bouchat, Sophie, et al.
Published: (2015)

Epigenetic therapy of acute myeloid leukemia using 5-aza-2'-deoxycytidine (decitabine) in combination with inhibitors of histone methylation and deacetylation
by: Momparler, Richard L, et al.
Published: (2014)

The PARP inhibitor Olaparib disrupts base excision repair of 5-aza-2′-deoxycytidine lesions
by: Orta, Manuel Luis, et al.
Published: (2014)

Effects of 5-aza-2′deoxycytidine on RECK gene expression and tumor invasion in salivary adenoid cystic carcinoma
by: Zhou, X.Q., et al.
Published: (2014)

Isoform switching and exon skipping induced by the DNA methylation inhibitor 5-Aza-2′-deoxycytidine
by: Ding, Xiao-Lei, et al.
Published: (2016)

5-Aza-2'-deoxycytidine acts as a modulator of chondrocyte hypertrophy and maturation in chick caudal region chondrocytes in culture
by: Haq, Samina Hyder
Published: (2016)

Aza-deoxycytidine induces apoptosis or differentiation via DNMT3B and targets embryonal carcinoma cells but not their differentiated derivatives
by: Wongtrakoongate, P, et al.
Published: (2014)

Demethylation of the miR-146a promoter by 5-Aza-2’-deoxycytidine correlates with delayed progression of castration-resistant prostate cancer
by: Wang, Xiaolu, et al.
Published: (2014)

Five-aza-2′-deoxycytidine-induced hypomethylation of cholesterol 25-hydroxylase gene is responsible for cell death of myelodysplasia/leukemia cells
by: Tsujioka, Takayuki, et al.
Published: (2015)

A subgroup of pancreatic adenocarcinoma is sensitive to the 5-aza-dC DNA methyltransferase inhibitor
by: Gayet, Odile, et al.
Published: (2014)

Dibenzylazanium chloride
by: Selvakumaran, N., et al.
Published: (2012)

Gene Reactivation by 5-Aza-2′-Deoxycytidine–Induced Demethylation Requires SRCAP–Mediated H2A.Z Insertion to Establish Nucleosome Depleted Regions
by: Yang, Xiaojing, et al.
Published: (2012)

Unlike Pancreatic Cancer Cells Pancreatic Cancer Associated Fibroblasts Display Minimal Gene Induction after 5-Aza-2′-Deoxycytidine
by: Yu, Jun, et al.
Published: (2012)

Developmental Competence and Pluripotency Gene Expression of Cattle Cloned Embryos Derived from Donor Cells Treated with 5-aza-2'-deoxycytidine
by: Jafarpour, Farnoosh, et al.
Published: (2011)

Dual Effects of Cigarette Smoke Extract on Proliferation of Endothelial Progenitor Cells and the Protective Effect of 5-aza-2′-deoxycytidine on EPCs against the Damage Caused by CSE
by: He, Zhi-Hui, et al.
Published: (2014)

Restoration of Epigenetically Silenced Sulfatase 1 Expression by 5-Aza-2′-Deoxycytidine Sensitizes Hepatocellular Carcinoma Cells to Chemotherapy-Induced Apoptosis
by: Shire, Abdirashid, et al.
Published: (2015)